ASCO-GI

ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
Fri, 01/20/23 - 10:19 am
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
ASCO-GI – immuno-oncology makes progress in liver cancer
EP Vantage
Fri, 01/21/22 - 10:37 am
AstraZeneca
Imfinizi
tremelimumab
ASCO-GI
liver cancer